2653 monitored
← Actor desksRead-only · existing recordsClassic graph view ↗

Sentinels / Actor desk

Prelude Therapeutics Incorporated Nasdaq

organization · Registry status: unverified

da486f8d-da5b-507a-a63e-db34db81f9bf

Evidence, not intent.

Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.

No claim of complete coverage or live monitoring.

Observation window

UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.

Recent observations / timeline

The source record

11 distinct events shown, newest first. Headlines may be generated summaries; inspect the source before repeating a claim.

  1. Corcept Therapeutics (NASDAQ:CORT) Insider Sean Maduck Sells 11,841 Shares of Stock

    Recorded role: co mention · TAX_FNCACT_PEER

    Open source ↗
  2. Corcept Therapeutics (CORT) Q3 2026 Earnings Call Transcript | The Motley Fool

    Recorded role: co mention · TAX_FNCACT_PHYSICIAN

    Open source ↗
  3. Corcept Therapeutics (NASDAQ:CORT) Releases Quarterly Earnings Results, Beats Expectations By $0.22 EPS

    Recorded role: co mention · GENERAL_HEALTH

    Open source ↗
  4. Corcept Therapeutics Q3 Earnings Call Highlights

    Recorded role: co mention · TAX_DISEASE_HYPERTROPHY

    Open source ↗
  5. Corcept Therapeutics (NASDAQ:CORT) Shares Climb 5% – Should You Buy?

    Recorded role: co mention · TAX_DISEASE_CUSHING_SYNDROME

    Open source ↗
  6. Corcept Reports Positive Phase 2 BELLA Results For Lifyorl In Platinum-Resistant Ovarian Cancer

    Recorded role: co mention · WB_698_TRADE

    Open source ↗
  7. Corcept Therapeutics Incorporated $CORT Stock Position Boosted by Nisa Investment Advisors LLC

    Recorded role: co mention · TAX_FNCACT_ANALYSTS

    Open source ↗
  8. Englebert Financial Advisers LLC Buys New Shares in Corcept Therapeutics Incorporated $CORT

    Recorded role: co mention · GENERAL_HEALTH

    Open source ↗
  9. Corcept Therapeutics (NASDAQ:CORT) vs. Ovid Therapeutics (NASDAQ:OVID) Head-To-Head Contrast

    Recorded role: co mention · TAX_DISEASE_SYNDROME

    Open source ↗
  10. Prelude Therapeutics, Lilly Partner To Evaluate PRT13722 In Breast Cancer Trial

    Recorded role: co mention · ECON_STOCKMARKET

    Open source ↗
  11. Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells $93,474.00 in Stock

    Recorded role: co mention · TAX_FNCACT_PRINCIPAL

    Open source ↗

Signals to inspect

Anomalies

Latest 3 in the selected window (up to 10). Detector output, not verified conclusions.

medium · new connection

New connection: 2 previously unseen co-actor(s) detected (known network: 24)

high · new connection

New connection: 3 previously unseen co-actor(s) detected (known network: 22)

medium · volume spike

Volume spike: 3 events in window (3.0x baseline of 1.0 expected)

Narrative context

Unresolved threads

Latest 20 at most, across all dates. Stored narratives require human review.

No unresolved threads recorded.

Stored connections

Relationships

Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.

Ask this desk

Desk analyst

Read-only questions about Prelude Therapeutics Incorporated Nasdaq's stored record. Answers cite only records retrieved for that turn; a citation chip opens the existing inspection view. Absence of matches is not evidence of inactivity.

Operator sign-in is required. Sign in

Identity is the existing actor registry record. Entity resolution and source coverage may be incomplete.